SP-0336: For the motion: particle therapy: randomised trials are obligator

D. De Ruysscher
2015 Radiotherapy and Oncology  
S166 3rd ESTRO Forum 2015 planning. After 3 months a complete response was observed in 46%, and 7% had partial response. Conclusions: Using the HYPERcollar, deep hyperthermia treatment of HNC was found to be safe, feasible, with good compliance and promising outcome. These promising early clinical results culminated in the use of hyperthermia as a standard addition to reirradiation. We will now embark on a study for (chemo-)irradiation combined with hyperthermia in primary head and neck cancer.
more » ... Debate: Particle therapy: Randomised trials are obligatory SP-0336 For the motion: particle therapy: randomised trials are obligatory
doi:10.1016/s0167-8140(15)40334-2 fatcat:5iigs26iq5dflb6qm7uquwurpm